Literature DB >> 15161685

Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis.

Alan K Meeker1, Jessica L Hicks, Christine A Iacobuzio-Donahue, Elizabeth A Montgomery, William H Westra, Theresa Y Chan, Brigitte M Ronnett, Angelo M De Marzo.   

Abstract

PURPOSE: Telomeres help maintain chromosomal integrity. Dysfunctional telomeres can cause genetic instability in vitro and an increased cancer incidence in telomerase knock out mouse models. We recently reported that telomere shortening was a prevalent alteration in human prostate, pancreas, and breast cancer precursor lesions. In the present study, we address whether the previous findings are broadly applicable to human epithelial cancer precursors in general. EXPERIMENTAL
DESIGN: Surgical specimens of epithelial cancer precursor lesions from the urinary bladder, esophagus, large intestine, oral cavity, and uterine cervix were examined using a recently developed technique for direct in situ telomere length assessment in formalin-fixed human tissue specimens.
RESULTS: Widespread telomere length abnormalities were nearly universal (97.1% of cases) in the preinvasive stages of human epithelial carcinogenesis in all sites examined in this series, with telomere shortening the predominant abnormality (88.6% of cases).
CONCLUSIONS: Telomere length abnormalities appear to be one of the earliest and most prevalent genetic alterations acquired in the multistep process of malignant transformation. These findings support a model whereby telomere dysfunction induces chromosomal instability as an initiating event in many, perhaps most, human epithelial cancers. Together with previous findings from the prostate and pancreas, the percentage of intraepithelial neoplasia lesions showing telomere length abnormalities is 95.6%. The implications of these findings include the potential that telomere length assessment in situ may be a widely useful biomarker for monitoring disease prevention strategies and for improved early diagnosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161685     DOI: 10.1158/1078-0432.CCR-0984-03

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  121 in total

1.  Telomere length variation in normal epithelial cells adjacent to tumor: potential biomarker for breast cancer local recurrence.

Authors:  Xin Zhou; Alan K Meeker; Kepher H Makambi; Ourania Kosti; Bhaskar V S Kallakury; Mary K Sidawy; Christopher A Loffredo; Yun-Ling Zheng
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

2.  Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.

Authors:  Enrica Rampazzo; Laura Bonaldi; Livio Trentin; Carlo Visco; Sonia Keppel; Silvia Giunco; Federica Frezzato; Monica Facco; Elisabetta Novella; Ilaria Giaretta; Paola Del Bianco; Gianpietro Semenzato; Anita De Rossi
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

Review 3.  Emerging roles of SIRT6 on telomere maintenance, DNA repair, metabolism and mammalian aging.

Authors:  Gaoxiang Jia; Ling Su; Sunil Singhal; Xiangguo Liu
Journal:  Mol Cell Biochem       Date:  2012-05       Impact factor: 3.396

4.  Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis.

Authors:  Elisabetta Kuhn; Alan Meeker; Tian-Li Wang; Ann Smith Sehdev; Robert J Kurman; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2010-06       Impact factor: 6.394

Review 5.  Assessing cell and organ senescence biomarkers.

Authors:  Bruno Bernardes de Jesus; Maria A Blasco
Journal:  Circ Res       Date:  2012-06-22       Impact factor: 17.367

6.  Allele-specific relative telomere lengths are inherited.

Authors:  Jesper Graakjaer; Héra Der-Sarkissian; Annette Schmitz; Jan Bayer; Gilles Thomas; Steen Kolvraa; José-Arturo Londoño-Vallejo
Journal:  Hum Genet       Date:  2006-01-27       Impact factor: 4.132

Review 7.  Epidemiologic evidence for a role of telomere dysfunction in cancer etiology.

Authors:  Jennifer Prescott; Ingrid M Wentzensen; Sharon A Savage; Immaculata De Vivo
Journal:  Mutat Res       Date:  2011-07-02       Impact factor: 2.433

Review 8.  Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes.

Authors:  M J Sampson; D A Hughes
Journal:  Diabetologia       Date:  2006-06-21       Impact factor: 10.122

9.  Isolation of chromatin from dysfunctional telomeres reveals an important role for Ring1b in NHEJ-mediated chromosome fusions.

Authors:  Cristina Bartocci; Jolene K Diedrich; Iliana Ouzounov; Julia Li; Andrea Piunti; Diego Pasini; John R Yates; Eros Lazzerini Denchi
Journal:  Cell Rep       Date:  2014-05-09       Impact factor: 9.423

Review 10.  Biology of telomeres: importance in etiology of esophageal cancer and as therapeutic target.

Authors:  Jagannath Pal; Jason S Gold; Nikhil C Munshi; Masood A Shammas
Journal:  Transl Res       Date:  2013-10-01       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.